Investing.com - Edwards Lifesciences (NYSE:EW) reported first quarter earnings that beat analysts' expectations on Thursday and revenue that topped forecasts.
The firm reported earnings per share of $1.51 on revenue of $1.13B. Analysts polled by Investing.com expected EPS of $1.37 on revenue of $1.11B. That compared to EPS of $1.32 on revenue of $993M in the same period a year earlier. The company had reported EPS of $1.46 on revenue of $1.17B in the previous quarter.
Edwards Lifesciences shares lost 0.73% to trade at $219.00 in after-hours trade following the report.
For the year, Edwards Lifesciences shares are down 5.44%, outperforming the S&P 500 which is down 13.8% year to date.
Edwards Lifesciences follows other major Healthcare sector earnings this month
On Tuesday, April 14, 2020, J&J reported first quarter EPS of $2.3 on revenue of $20.69B, compared to forecasts of EPS of $2.02 on revenue of $19.73B.
Abbott Labs earnings beat analyst's expectations on Thursday, April 16, 2020, with first quarter EPS of $0.65 on revenue of $7.73B. Investing.com analysts expected EPS of $0.59 on revenue of $7.44B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar